Jeffrey Modell Foundation supports Belgian research on primary immunodeficiency

(VIB (the Flanders Institute for Biotechnology)) For the first time the Jeffrey Modell Foundation is giving a research grant to a Belgian laboratory. The team of Adrian Liston from VIB-KU Leuven will use the grant to develop a gene therapy to cure children that suffer from IPEX syndrome, a rare and fatal autoimmune disorder in which the immune system attacks the body's own tissues and organs. At the moment, the only successful therapy to treat the syndrome is a bone marrow transplantation, which is not available for all children.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news